Quest IPO

Quest Laboratories Ltd

₹1,11,600 /1200 sharesMinimum Investment

Quest IPO Listing Details

Listed OnIssue PriceListing PriceListing Gains
--₹97.00₹155.10₹58.10 (59.90%)

Quest IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
15 May ‘24 - 17 May ‘24₹1,11,6001,200₹93 - ₹97
Issue SizeIPO Doc
43.16Cr
RHP PDF

About the company

Quest Laboratories Ltd is a manufacturer of pharmaceutical formulations, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, and antidepressants, among others. It produces ethical drugs, generic drugs, and over-the-counter drugs (OTC) in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. The company’s manufacturing facility is located at Dhar, Madhya Pradesh. The company operates in the domestic market across 12 states and 2 Union Territories of Uttar Pradesh, Madhya Pradesh, Maharashtra, Delhi, Jharkhand, Assam, Karnataka, Jammu & Kashmir, Rajasthan, West Bengal Gujarat, Telangana, Haryana and Bihar.;
Founded in
1998
Managing director
Anil Kumar Sabarwal
Parent organisation
Quest Laboratories Ltd

Strength and risks

Strengths
Risks
The company holds WHO Schedule M GMP; GLP and ISO 9001:2015 certifications. It also holds the ISO/IEC 17025:2017 accreditation. The company has the Good Laboratory Practice (GLP) certification issued by the Food & Drug Administration, Bhopal, Madhya Pradesh.
As per the RHP, the company has the requisite approvals to manufacture more than 600 formulations. The company routinely manufactures 250 to 300 different types of formulations, depending on market demand and the capacity of its limited formulation lines.
The company manufactures a variety of generic drugs – branded, OTC and specialised.
The company’s total income and profit after tax (PAT) have risen consistently over the years. For the period ended December 31, 2023 and for the financial years ended March 31, 2023, 2022 and 2021, revenue from operations stood at Rs 62.08 crore, Rs 61.64 crore, Rs 59.48 crore and Rs 30.36 crore, respectively, while PAT came in at Rs 7.75 crore, Rs 5.03 crore, Rs 4.11 crore and Rs 0.66 crore, respectively.

Financials

*All values are in Rs. Cr
No Graph Data To Display

Application details

Apply asPrice bandApply upto
Regular93 - 97₹2 Lakh
High Networth Individual93 - 97₹2 - 5 Lakh
For Quest IPO, eligible investors can apply as Regular.
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW